Neuropathic pain from damaged or malfunctioning nerves creates burning, shooting, or electric sensations that resist traditional pain medications. At Mend The Mind, we provide specialized ketamine therapy for diabetic neuropathy, post-herpetic neuralgia, nerve injury pain, and other neuropathic conditions that haven’t responded to conventional treatment. Our approach combines anesthesia-level medical expertise with evidence-based ketamine protocols specifically designed for nerve pain.
Unlike tissue damage pain that responds to anti-inflammatory medications or opioids, neuropathic pain requires targeted intervention at the level where pain signals are generated and amplified. Ketamine’s unique mechanism addresses the neural pathways maintaining chronic nerve pain, offering relief when other treatments have failed.
Neuropathic pain arises from damage to or dysfunction of the nervous system itself rather than from tissue injury. When nerves are damaged by diabetes, shingles, surgery, trauma, or other causes, they can begin sending persistent pain signals even without ongoing injury. This creates sensations fundamentally different from normal pain—burning that feels like fire under your skin, shooting pains like electric shocks, hypersensitivity where light touch feels agonizing, or deep aching that never fully resolves.
Common neuropathic pain conditions include diabetic peripheral neuropathy, where high blood sugar damages nerves in feet and legs, creating numbness, tingling, and burning pain. Post-herpetic neuralgia follows shingles outbreaks, leaving persistent pain in affected dermatomes long after the rash heals. Nerve injury from surgery or trauma can create chronic pain at injury sites or along nerve pathways. Complex regional pain syndrome produces severe pain disproportionate to initial injury, often with temperature changes and skin sensitivity. Chemotherapy-induced peripheral neuropathy affects patients receiving neurotoxic cancer treatments.
The mechanisms driving neuropathic pain differ from other pain types. Central sensitization occurs when your nervous system becomes hypersensitive, amplifying pain signals and triggering pain from normally innocuous stimuli. Ectopic nerve firing means damaged nerves generate spontaneous pain signals without external triggers. Neuroinflammation in damaged nerves and spinal cord perpetuates pain pathways. These changes create pain that persists independently of the original injury, essentially becoming its own disease process.
The impact extends beyond physical sensation. Constant burning or shooting pain disrupts sleep, making everything harder to manage. Depression and anxiety develop when pain dominates your mental landscape and limits what you can do. Social withdrawal happens as pain prevents participation in activities you once enjoyed. Work becomes difficult or impossible when nerve pain affects your hands, feet, or concentration. This constellation of effects makes effective neuropathic pain treatment essential for restoring quality of life.
Traditional pain medications work poorly for nerve pain because they target different mechanisms. Opioids provide minimal relief for neuropathic pain while carrying significant risks of tolerance, dependence, and side effects. The receptors opioids act on simply don’t address the neural dysfunction driving nerve pain. Anti-inflammatory medications like NSAIDs offer little benefit because neuropathic pain doesn’t stem from inflammatory processes in tissues.
First-line treatments for neuropathic pain include gabapentinoids like gabapentin and pregabalin, which calm overactive nerves. These help many patients but leave 40-60% with inadequate pain relief even at maximum doses. Antidepressants such as duloxetine and amitriptyline modulate pain pathways in the brain and spinal cord, providing moderate benefit for some patients but often causing intolerable side effects or incomplete relief.
The neural changes underlying neuropathic pain prove remarkably resistant to modification. Central sensitization means your nervous system has learned to amplify pain, creating persistent hypersensitivity. Neuroplastic changes reshape pain pathways through repeated activation, essentially training your nervous system to maintain pain. These alterations occur at multiple levels—peripheral nerves, spinal cord, and brain—making single-mechanism treatments insufficient.
Many patients with neuropathic pain cycle through multiple medications over years, experiencing modest improvement at best. The cumulative burden of failed treatments, persistent pain, and medication side effects creates treatment fatigue and hopelessness. Finding effective relief requires targeting the specific neural mechanisms maintaining nerve pain, which is where ketamine’s unique properties become valuable.
Ketamine addresses neuropathic pain through mechanisms distinctly different from traditional pain medications. As an NMDA receptor antagonist, ketamine blocks the receptors critically involved in central sensitization and pain pathway neuroplasticity. This interrupts the wind-up phenomenon where pain signals amplify through repeated activation, essentially resetting hypersensitive pain processing.
NMDA receptors play a central role in how your nervous system develops and maintains chronic pain states. When these receptors are repeatedly activated by persistent pain signals, they trigger neuroplastic changes that make pain processing more sensitive and persistent. Ketamine’s blockade of NMDA receptors prevents this sensitization and may help reverse already-established changes. This mechanism specifically targets nerve pain pathways that other medications don’t effectively address.
Research evidence for ketamine in neuropathic pain is stronger than for many other chronic pain conditions. Systematic reviews demonstrate significant pain reduction in diabetic neuropathy, with effects lasting days to weeks after treatment. Studies in post-herpetic neuralgia show meaningful relief when conventional treatments fail. Nerve injury pain from surgery or trauma responds to ketamine’s NMDA receptor blockade. Complex regional pain syndrome, notoriously difficult to treat, often improves with ketamine infusions where other interventions provide insufficient relief.
Ketamine also reduces neuroinflammation in damaged nerves and the spinal cord. It decreases production of pro-inflammatory cytokines that perpetuate pain pathways while promoting anti-inflammatory processes. This dual action—blocking pain amplification while reducing inflammation maintaining pain—makes ketamine particularly effective for neuropathic conditions.
The treatment protocols for neuropathic pain typically involve extended infusions lasting 2-4 hours rather than the 40-60 minute sessions used for depression. This prolonged receptor blockade appears necessary for meaningful pain pathway modification. Our anesthesia expertise ensures your safety throughout these longer sessions while maximizing therapeutic benefit.
Our primary neuropathic pain treatment uses IV ketamine delivered over 2-4 hours under continuous medical monitoring. Your Board Certified CRNA ensures both therapeutic effectiveness and medical safety throughout extended infusions. The longer infusion time allows sustained NMDA receptor blockade necessary for pain pathway modulation.
Initial protocols typically involve 4-6 infusions scheduled 1-2 times weekly, though we adjust timing based on your response patterns and pain levels. Dosing for neuropathic pain may differ from depression protocols, with adjustments made based on your specific condition, pain intensity, and how you respond to treatment. The goal is meaningful pain reduction without excessive dissociative effects, though some altered consciousness during infusions is normal and expected.
During treatment, you’ll experience dissociation, altered perception, and deep relaxation as ketamine takes effect. These sensations are temporary and resolve within 1-2 hours after infusion ends. Many patients describe profound relaxation and temporary freedom from pain during sessions, with therapeutic effects extending well beyond the infusion itself.
Following your initial treatment series, maintenance infusions help sustain pain relief. Frequency varies based on how long benefits last—some patients need monthly treatments while others go several months between infusions. We work with you to identify the optimal maintenance schedule that keeps pain manageable while minimizing treatment burden.
For ongoing neuropathic pain management between IV treatments, ketamine troches provide at-home relief. These prescription oral ketamine lozenges offer flexibility for maintaining pain control without requiring clinic visits. Many patients use troches as a bridge between IV infusions or transition to troches for long-term maintenance after completing their initial IV series.
Troches work best when combined with periodic IV treatments rather than as standalone therapy. The IV infusions provide deeper pain pathway modification while troches maintain benefits between sessions. This combined approach often achieves better sustained relief than either treatment alone.
Ketamine works most effectively as part of comprehensive neuropathic pain management rather than isolated treatment. Our psychiatric medication expertise ensures your gabapentinoids, antidepressants, and other pain medications are optimally dosed and coordinated. As ketamine provides relief, we can often reduce medications with troublesome side effects or adjust regimens for better overall outcomes.
Many patients benefit from combining ketamine with appropriate long-term medications, addressing nerve pain through multiple mechanisms simultaneously. We help you find the medication combination that maximizes pain relief while minimizing side effects and treatment burden.
When neuropathic pain intertwines with tension patterns or psychological stress, somatic work during ketamine sessions helps address mind-body dimensions. You’ll focus on physical sensations and nervous system regulation during treatment, learning to relate to pain differently and develop regulation skills that reduce pain intensity.
This approach proves particularly valuable when nerve pain creates protective tension patterns, anxiety amplifies pain perception, or you’ve developed fear-avoidance behaviors limiting your function. The body-centered work complements ketamine’s neurological effects by addressing behavioral and psychological factors maintaining pain.
Neuropathic pain shows stronger and more consistent response to ketamine than many other chronic pain conditions. Research demonstrates meaningful pain reduction in 50-70% of patients with various neuropathic pain types. The evidence base is more robust than for fibromyalgia or other non-neuropathic chronic pain conditions.
Response patterns vary among individuals. Some patients experience significant pain reduction—50% or more improvement—allowing return to activities and better quality of life. Others notice moderate benefits that make pain more manageable even without complete relief. A minority experience minimal improvement, though neuropathic pain responds better to ketamine than most other pain types.
Pain relief timeline differs from mental health applications. Some patients notice reduced pain during or immediately after infusion, while others require 2-3 treatments before experiencing meaningful benefit. Maximum relief often builds across the full initial series rather than appearing after single treatments. Effects typically extend days to weeks beyond each infusion, with cumulative benefits across multiple sessions.
Maintenance treatment sustains long-term relief. Most patients need ongoing infusions—monthly to quarterly depending on individual response—to maintain pain reduction achieved during initial treatment. This isn’t treatment failure but reflects the persistent nature of neuropathic pain mechanisms. Regular maintenance prevents pain from returning to pre-treatment levels.
Realistic expectations matter for treatment satisfaction. Ketamine rarely eliminates neuropathic pain completely but can reduce intensity enough to dramatically improve functioning and quality of life. Even 30-40% pain reduction often allows return to work, better sleep, reduced medication needs, and restoration of activities pain previously prevented.
You may benefit from ketamine therapy for neuropathic pain if conventional treatments including gabapentinoids and antidepressants provide inadequate relief, your nerve pain significantly impacts daily functioning and quality of life, you have diabetic neuropathy, post-herpetic neuralgia, nerve injury pain, or complex regional pain syndrome, or you’re seeking alternatives to long-term opioid therapy for nerve pain.
Ketamine represents a treatment option for resistant neuropathic pain rather than first-line intervention. You should have tried appropriate conventional approaches first including medications specific to neuropathic pain like gabapentin, pregabalin, or duloxetine, physical therapy or other rehabilitation if relevant to your condition, and treatment of underlying causes when possible like optimizing diabetes control. Ketamine serves best when standard treatments have been inadequate rather than as initial intervention.
Medical clearance ensures you’re safe for ketamine treatment. Uncontrolled cardiovascular disease requires optimization before proceeding. Active substance use disorders need addressing prior to ketamine therapy. Certain psychiatric conditions require careful evaluation. We review your complete medical history to ensure ketamine is appropriate and safe for your situation.
Treatment requires commitment to the initial protocol and potentially ongoing maintenance. You’ll need ability to attend regular appointments during initial treatment, transportation home after each infusion as you cannot drive, adequate support system during your treatment course, and realistic expectations about outcomes and maintenance needs. Success requires active participation in your treatment plan rather than passive receipt of therapy.
Neuropathic pain doesn’t have to control your life. Our specialized approach combines evidence-based ketamine therapy with comprehensive pain management expertise, delivered with anesthesia-level safety standards. We understand the frustration of nerve pain that resists conventional treatment, and we’re here to help you find relief when other approaches haven’t worked.
[1] Jonkman, K., et al. (2021). “Efficacy of ketamine in relieving neuropathic pain: a systematic review and meta-analysis of animal studies.” PAIN, 162(9), 2277-2288. https://journals.lww.com/pain/fulltext/2021/09000/efficacy_of_ketamine_in_relieving_neuropathic.3.aspx
[2] McNicol, E. D., et al. (2022). “Efficacy and Safety of Ketamine in the Treatment of Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Pain Medicine, 23(4), 737-750. https://pmc.ncbi.nlm.nih.gov/articles/PMC9007468/
Conditions Treated
1201 U.S. Highway 10 W, Unit A4, Livingston 59047
Mend The Mind is a psychiatric practice in Livingston, Montana, specializing in ketamine therapy and comprehensive mental health services for adults. With anesthesia expertise ensuring the highest safety standards, we bring evidence-based treatment to rural Montana communities.